BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 1999
View Archived Issues
Company Profile: NeuroVir
Read More
Chromium picolinate identified as insulin assistance factor
Read More
La Jolla presents new Toleragen compound with potential to treat autoimmune blood clotting disorder
Read More
Genset signs collaboration with Johns Hopkins for schizophrenia gene identification
Read More
Roberts will distribute emergency contraceptive kit in Canada
Read More
Phase III trial results presented for Leukine in AIDS
Read More
Postmarketing studies of latanoprost support efficacy, safety of antiglaucoma agent
Read More
Microtubule disruption by T-138067 produces potent anticancer activity in MDR tumors
Read More
Cholesteryl ester transfer protein inhibitors patented by Bayer
Read More
Antiinflammatory and analgesic pyrazoles described by Fujisawa
Read More
Roche team synthesizes new series of PLA2 inhibitors
Read More
Glaxo reports kinase inhibitors especially useful for chemotherapy-induced alopecia
Read More
Vitronectin receptor antagonists from SB for osteoporosis, cancer, etc.
Read More
Cytokine-inhibitory aminotetralines synthesized and evaluated at Sigma-Tau
Read More
OraVax and Peptide Therapeutics merger completed this week
Read More
Clinical trials of OP-2000 for IBD to begin later this year
Read More
IntraDose NDA to receive fast track review by FDA
Read More
RB-2121, an anti-HIV agent directed to a novel antiretroviral target
Read More
RFS-2000 (now rubitecan) advances in clinical trials in over 10 tumor types
Read More
ONYX-015 now under clinical evaluation for chemopreventive potential
Read More
RD3-0028 is effective in treating RSV infection in mice
Read More
Periodontix announces phase I/II trial of histatin-based mouthwash for oral candidiasis
Read More
Planned accelerated full merger of Rhone-Poulenc and Hoechst moves ahead
Read More
Approvable letter for Exelon NDA issued by FDA
Read More
Company Profile: Message Pharmaceuticals
Read More
U.S. patent issues to Cytogen for PSMA-specific abtides
Read More
Tranilast evaluated in dog model of intimal hyperplasia following vascular injury
Read More
Ribi ImmunoChem: Q1 1999 highlights
Read More
DSMB approves continuation of phase III trial of Flocor in sickle cell crisis
Read More
Genzyme Molecular Oncology outlines development plans at recent analysts meeting
Read More